Familial Hypercholesterolemia (FH)
The FH Foundation announced the publication of a  consensus statement on the application of genetic testing in diagnosing familial hypercholesterolemia (FH) in the  Journal of the American College of Cardiology in July 2018 . A culmination of a two-year effort led by the FH Foundation and authored by an international panel of 30 cardiovascular, lipid, genetics and advocacy experts,  the statement recommends that genetic testing be offered to diagnose both individuals with FH and their relatives .
 
Resources, videos and tools for healthcare professionals and individuals with FH are available on the FH Foundation website to support consideration of genetic testing.
 
In addition, we are pleased to share this upcoming webinar for healthcare professionals hosted by the National Lipid Association.
Clinical Utility of Genetic Testing in the Diagnosis of Familial Hypercholesterolemia

 Thursday, October 25th | 6:00 pm – 7:00 pm EST
The National Lipid Association invites you to participate in our complimentary webinar, "Clinical Utility of Genetic Testing in the Diagnosis of Familial Hypercholesterolemia." Join Alan S. Brown, MD, FNLA and Amy C. Sturm, MS, LGC as they discuss the use of genetic testing in the diagnosis of patients with familial hypercholesterolemia (FH). They will review genetic vs. clinical diagnoses, the current diagnosis recommendations and guidelines, the importance, and burden, of screening your patients' families, and the latest articles from experts in the field.
Support for this webinar has been provided by Quest Diagnostics. 
Key illustration from the recently published "Clinical Genetic Testing for Familial Hypercholesterolemia" in the  Journal of the American College of Cardiology.
Sturm, AC et al. J Am Coll Cardiol.2018;72(6):662-80